Relmada Therapeutics, Inc. RLMD Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s common stock shares issued?
- Relmada Therapeutics, Inc. (RLMD) reported common stock shares issued of 104.9M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s common stock shares issued changed year-over-year?
- Relmada Therapeutics, Inc.'s common stock shares issued increased by 3376.2% year-over-year, from 3M to 104.9M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s common stock shares issued?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s common stock shares issued has grown at a 35.0% compound annual growth rate (CAGR), from 16.3M to 73.3M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.